38
In Vitro Fertilization: the basics…. Molina B. Dayal, MD Medical Director Sher Institute for Reproductive Medicine, St. Louis

Seminar Presentation Molina Dayal MD 9-13

Embed Size (px)

DESCRIPTION

The basics of In Vitro Fertilization. Presented by Molina Dayal, MD of the Sher Institute for Reproductive Medicine

Citation preview

Page 1: Seminar Presentation Molina Dayal MD 9-13

In Vitro Fertilization: the basics….

Molina B. Dayal, MD

Medical Director

Sher Institute for Reproductive Medicine, St. Louis

Page 2: Seminar Presentation Molina Dayal MD 9-13

All Couples1 in 8 Couples

Age 30-341 in 6 Couples

Age 35-391 in 4 Couples

Age 40-441 in 2 Couples

Page 3: Seminar Presentation Molina Dayal MD 9-13

Inability to conceive after one year’s worth of regular unprotected intercourse:

Can this be applied to everyone?

Age.

Ovulatory status.

Known tubal or male issues.

Page 4: Seminar Presentation Molina Dayal MD 9-13

Infertility --- Basic Statistics

20-25% couples conceive/month in 1st year

85% of couples will have conceived in one year

Those 15% who did not conceive will have a monthly chance of conception of 2-3%/month

2-3%/month is achieved after just 6 months if the woman is 35 years old or older

Page 5: Seminar Presentation Molina Dayal MD 9-13

Causes of infertility

• Ovulatory Factor

• Egg Factor

• Tubal Factor

• Uterine Factor

Sperm Quality

50%

10%

40%

Unknown

Immunologic

Page 6: Seminar Presentation Molina Dayal MD 9-13

Assessment of ovulation

Ovarian reserve screening

Assessment of pelvic anatomy

(Hysterosalpingogram (HSG))

Semen Analysis

Immunologic

Page 7: Seminar Presentation Molina Dayal MD 9-13

What should be done with the information?

Page 8: Seminar Presentation Molina Dayal MD 9-13

Cause of Infertility

• Ovulatory Factor

• Decreased Ovarian Reserve

• Tubal Blockage Or Abnormality

Treatment

• Ovulation Induction• Clomid, etc

• IVF• ?Egg donor

• IVF• Surgery very unlikely to be

successful

Page 9: Seminar Presentation Molina Dayal MD 9-13

Cause of Infertility

• Mild Male Factor

• Moderate to Severe Male Factor

• Uterine Factor

Treatment

• Fertility Meds + IUI

• IVF (ICSI)

• Surgery

Page 10: Seminar Presentation Molina Dayal MD 9-13

Cause of Infertility

• Unexplained

• Immunologic

Treatment

•Fertility Meds + IUI

•IVF

Page 11: Seminar Presentation Molina Dayal MD 9-13

A few words about Intrauterine Insemination (IUI)

Page 12: Seminar Presentation Molina Dayal MD 9-13

Overall IUI Success Rates

15% for women under the age of 30, 12% for women ages 30 to 35, 7% to 8% for women ages 35 to 39< 2% for women over the age of 40.

Page 13: Seminar Presentation Molina Dayal MD 9-13

Clomid with IUI

Success rate dependent on age of female and sperm quality of male

<35 years old ---- 10%

35-40 years old ---- 5%

>40 years old ---- <2%

Unfortunately, Clomid can have a negative impact on uterine lining (therefore approx ½ chance of success compared to overall chance with IUI)

Page 14: Seminar Presentation Molina Dayal MD 9-13

Unexplained Infertility: Intrauterine Insemination

Study Likelihood of Pregnancy per Month

IUI vs. No treatment 4% vs. 3%

Clomid alone vs. No treatment 3% vs. 3%

Clomid + IUI vs. No treatment 8% vs. 3%

FSH inj + IUI vs No treatment 12% vs. 3%

Page 15: Seminar Presentation Molina Dayal MD 9-13

Intrauterine Insemination (IUI)

Page 16: Seminar Presentation Molina Dayal MD 9-13

IVF is oftentimes thought of as a ‘last resort’ but it shouldn’t be….

Page 17: Seminar Presentation Molina Dayal MD 9-13

IVF should be considered as the FIRST line treatment if….

Male factor (abnormal semen analysis)

Tubal factor (blocked or diseased fallopian tubes)

Advanced maternal age

Pre-implantation genetic diagnosis/cGH testing

Page 18: Seminar Presentation Molina Dayal MD 9-13

IVF should be considered as the FIRST line treatment if….

Pre-implantation genetic diagnosis (single gene disorders/disease carrier states)

Protracted infertility

Immunologic Implantation Dysfunction

Need for gestational carrier

Fertility Preservation

Page 19: Seminar Presentation Molina Dayal MD 9-13

What is IVF?

It is the fertilization of eggs with sperm/generation of embryos outside the body

Multi-step process

Medications (“protocols”) for patients are individualized to optimize outcome

Page 20: Seminar Presentation Molina Dayal MD 9-13

IVF: Manipulation of Normal Physiology

FSH

E2

Page 21: Seminar Presentation Molina Dayal MD 9-13

Deprogramming

Birth control pill

Lupron

Ganirelix

De-programs hypothalamic/pituitary axis.

Prevents ovulatory/LH surge.

Page 22: Seminar Presentation Molina Dayal MD 9-13

Stimulation of Follicles

Using FSH (follicle stimulating hormone) to stimulate follicles

Page 23: Seminar Presentation Molina Dayal MD 9-13

Ultrasound Guided Oocyte Retrieval

Page 24: Seminar Presentation Molina Dayal MD 9-13

The Fertilization Procedure

Intracytoplasmic Sperm Injection(ICSI)

Page 25: Seminar Presentation Molina Dayal MD 9-13

Fertilization Check

Page 26: Seminar Presentation Molina Dayal MD 9-13

Embryos at the Blastocyst Stage

Page 27: Seminar Presentation Molina Dayal MD 9-13

Embryo transfer

Page 28: Seminar Presentation Molina Dayal MD 9-13

Solving the Embryo Selection Dilemma

Blastocyst transfer

cGH testing

Page 29: Seminar Presentation Molina Dayal MD 9-13

Embryo Selection Dilemma

Issues related to the transfer of early cleavage stage (day 3) embryos

- Which is normal?

Morphology scoring:Cleavage rate.

Blastomere symmetry.Degree of fragmentation.

Page 30: Seminar Presentation Molina Dayal MD 9-13

Embryo Aneuploidy

40/normal appearance 67%

40/abnormal appearance 70%

Munne et al, Fertil Steril. 1995.

Chromosomal abnormality rates in embryos increase with maternal age even if the embryos appear normal

Age/Embryo Type (on day 3):Rate of Chromosome

Abnormalities:

Page 31: Seminar Presentation Molina Dayal MD 9-13

Why a blastocyst transfer?

Depending on maternal age, the majority of blastocysts are chromosomally normal.

More efficient (less risk of high order multiple pregnancies).

More physiologic.

Page 32: Seminar Presentation Molina Dayal MD 9-13

Why cGH?

While the majority of blastocysts are normal in younger women, this does not hold entirely true in older women.

Able to screen embryos, with high accuracy, for chromosomal abnormalities (Down Syndrome, etc) before an embryo transfer is performed.

Page 33: Seminar Presentation Molina Dayal MD 9-13

Testing for Aneuploidy/Single Gene Disorders:The Embryo Biopsy

Page 34: Seminar Presentation Molina Dayal MD 9-13

Following Embryo Biopsy

Report generated indicating findings from genetic analysis.

Patient and physician decide how many and which embryos to transfer.

Normal embryos are transferred/stored for later use while abnormal ones are disposed.

Page 35: Seminar Presentation Molina Dayal MD 9-13

Additional Advantages of IVF

Assessment of ovarian reserve.

Assessment of fertilization.

Control number of embryos placed in uterus.

Ability to freeze/store embryos for later use.

Page 36: Seminar Presentation Molina Dayal MD 9-13

Take Away Points

Seek evaluation from a fertility specialist after one year of infertility (or sooner if the woman >35 years old, has irregular cycles or there is a known male factor)

Consider fertility medications + IUI in cases of unexplained infertility, limiting treatment to no more than 3 attempts

Consider IVF as first line treatment when ovarian reserve is of concern, tubal disease/blockage and male factor are present, multiple IUI’s have failed, if an immunologic implantation issue is discovered, or you are interested in cGH testing.

Page 37: Seminar Presentation Molina Dayal MD 9-13

Thank you!

Page 38: Seminar Presentation Molina Dayal MD 9-13